Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Researchers reviewed health records for over 220,000 smokers with type 2 diabetes who received a new prescription for the GLP-1 receptor agonist semaglutide or seven other anti-diabetes medications
See our pricing page for more information
Implications for employers: Many of those who stop GLP-1 medications do so because they do not have coverage and cannot afford to continue
It can also become difficult to get the nutrition you need
Patient testimonials frequently describe profound disappointment when weekly injections fail to produce anticipated results
US$ 21.21
US$ 24.53
US$ 25.47
